KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Michal ŠMÍDA. Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies. In 60th ASH Annual meeting, San Diego, USA in Blood 2018. 2018. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1480242, author = {Kozlová, Veronika and Ledererová, Aneta and Doubek, Michael and Mayer, Jiří and Pospíšilová, Šárka and Šmída, Michal}, booktitle = {60th ASH Annual meeting, San Diego, USA in Blood 2018}, keywords = {Aurora; CD20; CLL; monoclonal}, language = {eng}, title = {Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies}, year = {2018} }
TY - CONF ID - 1480242 AU - Kozlová, Veronika - Ledererová, Aneta - Doubek, Michael - Mayer, Jiří - Pospíšilová, Šárka - Šmída, Michal PY - 2018 TI - Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies KW - Aurora KW - CD20 KW - CLL KW - monoclonal N2 - Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies, Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies. ER -
KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Michal ŠMÍDA. Epigenetic drug screen on resistant CLL cells reveals Aurora kinase inhibitors as enhancers of CD20 expression and sensitizers to treatment with CD20 monoclonal antibodies. In \textit{60th ASH Annual meeting, San Diego, USA in Blood 2018}. 2018.
|